Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Total 13F shares
-
99,013,834
-
Share change
-
-2,616,888
-
Total reported value
-
$3,576,956,736
-
Put/Call ratio
-
106%
-
Price per share
-
$36.12
-
Number of holders
-
351
-
Value change
-
-$93,583,862
-
Number of buys
-
150
-
Number of sells
-
180
Institutional Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q3 2025
As of 30 Sep 2025,
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) was held by
351 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
99,013,834 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, Clearbridge Investments, LLC, Soleus Capital Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, Pictet Asset Management Holding SA, Hood River Capital Management LLC, GOLDMAN SACHS GROUP INC, and NORTHERN TRUST CORP.
This page lists
351
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.